Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,190,165 papers from all fields of science
Search
Sign In
Create Free Account
DP 1904
Known as:
DP-1904
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
nafagrel
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Down-regulation of lipoxin A4 receptor by thromboxane A2 signaling in RAW246.7 cells in vitro and bleomycin-induced lung fibrosis in vivo.
Yoshinori Sato
,
H. Kitasato
,
+5 authors
I. Hayashi
Biomedicine & pharmacotherapy = Biomedecine…
2004
Corpus ID: 20085049
2001
2001
Thromboxane A(2) causes retarded clearance of aggregated protein in glomeruli of nephritic mice.
T. Nagao
,
J. Koseki
,
Y. Suzuki
,
T. Nagamatsu
European Journal of Pharmacology
2001
Corpus ID: 23808462
1999
1999
In vitro responses to antigen stimulation: comparison between human lung parenchyma resected from asthmatic patients and non-asthmatic patients.
C. Fukushima
,
T. Shimoda
,
+6 authors
S. Kohno
Annals of Allergy, Asthma & Immunology
1999
Corpus ID: 1654724
1998
1998
Correlative alteration of thromboxane A2 with antigen-induced bronchoconstriction and the role of platelets as a source of TXA2 synthesis in guinea pigs: effect of DP-1904, an inhibitor of…
M. Takami
,
W. Tsukada
Pharmacological Research
1998
Corpus ID: 6641049
A marked and sustained bronchoconstriction after antigen challenge was produced in actively sensitised guinea pigs, and…
Expand
1996
1996
Effect of DP-1904, a thromboxane A2 synthase inhibitor, on passive Heymann nephritis in rats.
T. Nagao
,
Tadashi Nagamatsu
,
Yoshio Suzuki
European Journal of Pharmacology
1996
Corpus ID: 45051412
1996
1996
Pharmacokinetic-pharmacodynamic modelling of DP-1904, a novel thromboxane synthetase inhibitor in rabbits, based on an indirect response model
N. Zheng
,
H. Sato
,
I. Adachi
,
I. Horikoshi
European journal of drug metabolism and…
1996
Corpus ID: 21214903
SummaryA new imidazole derivative, DP-1904, produces a selective, potent and long-acting inhibition of thromboxane A2 (TXA2…
Expand
1995
1995
Effect of DP-1904, a thromboxane A2 synthase inhibitor, administered from the autologous phase on crescentic-type anti-GBM nephritis in rats.
T. Nagao
,
T. Nagamatsu
,
Y. Suzuki
Japanese Journal of Pharmacology
1995
Corpus ID: 9213541
The antinephritic effect of DP-1904 [6-(1-imidazolylmethyl)-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid hydrochloride], a…
Expand
1994
1994
DP-1904, a specific inhibitor of thromboxane A2 synthesizing enzyme, suppresses ICAM-1 expression by stimulated vascular endothelial cells.
T. Ishizuka
,
K. Suzuki
,
+4 authors
H. Nakamura
European Journal of Pharmacology
1994
Corpus ID: 22491062
1992
1992
A thromboxane A2 synthetase inhibitor retards hypertensive rat diabetic nephropathy.
H. Masumura
,
S. Kunitada
,
K. Irie
,
S. Ashida
,
Y. Abe
European Journal of Pharmacology
1992
Corpus ID: 45827070
1991
1991
A thromboxane A2 synthase inhibitor, DP-1904, prevents rat renal injury.
H. Masumura
,
S. Kunitada
,
K. Irie
,
S. Ashida
,
Y. Abe
European Journal of Pharmacology
1991
Corpus ID: 4549295
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE